A study uncovers how cancer cells adapt to low-glucose environments, resisting chemotherapy by conserving uridine nucleotides ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

COVINGTON, Ky., Nov. 18, 2024 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and ...

We eventually decided to study photobiomodulation as an alternative to combat the pain caused by diabetic neuropathy," Kusahara said. The participants were divided randomly into two subgroups.

Chemo-induced anemia isn’t something we hear about as often as, say, hair loss, but it is a very common and undertreated side effect of chemotherapy. Anemia can result in fatigue and lightheadedness ...

It often responds initially to chemotherapy but is the most common breast cancer to recur. When it recurs, triple-negative breast cancer portrays chemotherapy resistance, making it less responsive and ...

Gorgas, President and CEO of Artelo Biosciences. “Starting with ART26.12, our promising Fatty Acid Binding Protein 5 (FABP5) inhibitor drug candidate, we received FDA clearance to begin trials in ...

Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients ...